Accelerating Non-Communicable Disease Prevention and Care for Every Child
Eli Lilly and Company and UNICEF
A healthy life begins with a healthy start.
That is why, since 2022, Eli Lilly and Company has supported UNICEF USA which enables UNICEF’s efforts to accelerate non-communicable disease (NCD) prevention and care for children and adolescents in resource-limited settings in Bangladesh, Malawi, Nepal,
the Philippines and Zimbabwe.
Thanks to Lilly’s support, UNICEF is reaching millions of children and caregivers, strengthening national health systems and training tens of thousands of health workers to better prevent, detect and treat childhood NCDs.
UNICEF has reached almost 16 million young people and caregivers … and counting.
What Are Non-Communicable Diseases?
Our Collaboration
“One of the major ways we address NCDs is through our Lilly 30x30 work — our corporate effort to improve access to quality health care for 30 million people living in resource-limited settings, each year, by 2030.
Our collaboration and support of UNICEF USA place children
at the center of the global agenda to address the NCD burden by
strengthening health care systems on the ground.
Every Lilly employee should be proud that, through this initiative,
we’ve changed the lives of millions.”
Cynthia Cardona, VP of Social Impact at Eli Lilly and Company, talks to Michele Walsh, EVP and Chief Philanthropy Officer at UNICEF USA Za
Cynthia Cardona, VP of Social Impact at Eli Lilly and Company, talks to Michele Walsh, EVP and Chief Philanthropy Officer at UNICEF USA Za
CEF
Our Collaboration
“One of the major ways we address NCDs is through our Lilly 30x30 work — our corporate effort to improve access to quality health care for 30 million people living in resource-limited settings, each year, by 2030.
Our collaboration and support of UNICEF USA place children
at the center of the global agenda to address the NCD burden by
strengthening health care systems on the ground.
Every Lilly employee should be proud that, through this initiative,
we’ve changed the lives of millions.”
Cynthia Cardona, VP of Social Impact at Eli Lilly and Company, talks to Michele Walsh, EVP and Chief Philanthropy Officer at UNICEF USA Za
Cynthia Cardona, VP of Social Impact at Eli Lilly and Company, talks to Michele Walsh, EVP and Chief Philanthropy Officer at UNICEF USA Za
CEF US
Progress Snapshot
Scroll to see UNICEF’s progress advancing childhood NCD prevention and care in 5 countries and improving outcomes for severe chronic conditions like type 1 diabetes, rheumatic and congenital heart disease and sickle cell.
Progress Snapshot
Scroll to see UNICEF’s progress advancing childhood NCD prevention and care in 5 countries and improving outcomes for severe chronic conditions like type 1 diabetes, rheumatic and congenital heart disease and sickle cell.
Malawi
Zimbabwe
Nepal
Bangladesh
Philippines
Patient Stories
Meet Chifundo, Sarita, Mohona and Kelly — four children at the center of our work to advance NCD health care.
Meet Chifundo, Sarita, Mohona and Kelly — four children at the center of our work to advance NCD health care.
Health Systems Strengthening
from the ground up
Dr. Carla Ante Orozo, Child Health Specialist, UNICEF Philippines
Dr. Carla Ante Orozo, Child Health Specialist, UNICEF Philippines
CEF USA
Advocacy for Children
UNICEF's ongoing work in the Philippines highlights urgent efforts to scale up childhood NCD advocacy and to secure national coverage for essential care and support.
Advocacy for Children
UNICEF's ongoing work in the Philippines highlights urgent efforts to scale up childhood NCD advocacy and to secure national coverage for essential care and support.
Dr. Carla Ante Orozo, Child Health Specialist, UNICEF Philippines
Dr. Carla Ante Orozo, Child Health Specialist, UNICEF Philippines
CEF USA
Our Collective Impact
Thanks to Lilly's support to UNICEF USA,
UNICEF has impacted millions of young people,
families and caregivers in resource-limited settings.
Health Care Access
Reached 102,200+ children and adolescents with NCD
care and support
Capacity Building
Trained 28,600+ facility and community-based health workers in NCD prevention, diagnosis or management
Community Outreach
Engaged 15.9+ million children and families with NCD awareness and behavior change campaigns
Advocacy Impact
Integrated childhood NCD indicators into national health management systems in key countries
Scaling Reach
In May 2026, Lilly’s collaboration with UNICEF
will enable UNICEF to scale efforts to reach even more children, young people and their families with NCD prevention, detection and treatment.
UNICEF programs will support resource-limited settings across 21 geographies in
Africa, Asia, and Latin America.
This next phase aims to improve access to quality health care for an additional 30 million young people and caregivers.
Scaling Reach
In May 2026, Lilly’s collaboration with UNICEF will enable UNICEF to scale efforts to reach even more children, young people and their families with NCD prevention, detection and treatment.
UNICEF programs will support resource-limited settings across 21 geographies
in Africa, Asia, and Latin America.
This next phase aims to improve access to quality health care for an additional 30 million young people and caregivers.
Making It Last
A Message from Kitty van der Heijden,
UNICEF Deputy Executive Director
"Millions of children are deprived of the building blocks necessary
for lifelong health due to non-communicable disease risk factors
established early in life. Our collaboration with Lilly
is leading the way to ensure children get a healthy start in life.
Through sustainable initiatives, we are accelerating NCD prevention and care in low- and middle-income countries. Our work demonstrates the impact that can be achieved when UNICEF and the private sector collaborate to drive results at scale.
Ensuring children have a healthy start begins with us all. UNICEF is calling on all sectors to join this work to give children a healthy start and the future they deserve.
Let’s make children’s health everyone’s business."
Learn more
about partnering with UNICEF
UNICEF does not endorse any company, brand, organization, product or service.
Built with Shorthand